Genetically Modified Organism (GMO)

A genetically modified organism (GMO) is a living organism whose genome has been deliberately altered through recombinant DNA technology, gene insertion, or gene editing, producing combinations of genetic material that do not occur through mating or natural recombination. The international legal architecture rests on the Cartagena Protocol on Biosafety, adopted in Montreal on 29 January 2000 under the Convention on Biological Diversity and in force from 11 September 2003, which uses the synonymous term "living modified organism" (LMO) and establishes the Advance Informed Agreement procedure for transboundary movement. India ratified the Convention on Biological Diversity in 1994 and the Cartagena Protocol in 2003. Domestically, the governing instrument is the Environment (Protection) Act, 1986, under which the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells were notified in 1989, commonly called the "1989 Rules." These rules vest regulatory authority across a multi-tier committee structure that remains the operative law for any GMO released or studied in India.

The procedural mechanics of GMO regulation in India proceed through a defined hierarchy of competent authorities. An institution conducting research first constitutes an Institutional Biosafety Committee (IBSC), which supervises contained laboratory work and reports to higher bodies. The Review Committee on Genetic Manipulation (RCGM), housed in the Department of Biotechnology, monitors ongoing research, small-scale field trials, and the safety of recombinant work. The apex body is the Genetic Engineering Appraisal Committee (GEAC), functioning under the Ministry of Environment, Forest and Climate Change, which grants approval for large-scale environmental release, commercial cultivation, and import of GM products. Approval requires the applicant to submit biosafety data covering allergenicity, toxicity, gene-flow risk, and environmental impact; the GEAC reviews this against the precautionary principle before issuing or denying clearance, and its decisions are subject to ministerial concurrence.

Beyond cultivation, parallel mechanics govern processed GM food and labelling. The Food Safety and Standards Authority of India (FSSAI), operating under the Food Safety and Standards Act, 2006, holds statutory mandate over genetically engineered food, and the Legal Metrology (Packaged Commodities) Rules require declaration of GM content on packaged goods above prescribed thresholds. Two principal techniques distinguish GMO categories: transgenesis, which inserts a gene from a different species—such as the Bacillus thuringiensis (Bt) gene into cotton—and cisgenesis or modern genome editing using CRISPR-Cas9, which alters native sequences. In 2022, the Ministry of Environment exempted certain gene-edited plants, specifically those falling under categories SDN-1 and SDN-2 that carry no foreign DNA, from the stringent GEAC biosafety clearance, signalling a regulatory divergence between transgenic and edited organisms.

India's only commercially approved GM crop is Bt cotton, cleared by the GEAC in 2002 and now covering the overwhelming majority of national cotton acreage. Bt brinjal received GEAC clearance in 2009, but Environment Minister Jairam Ramesh imposed an indefinite moratorium in February 2010 after public consultations, and it remains unreleased. GM mustard (DMH-11), developed by the Centre for Genetic Manipulation of Crop Plants at the University of Delhi, was recommended for environmental release by the GEAC in October 2022, a decision challenged before the Supreme Court of India, which delivered a split verdict in July 2024 and referred the matter for fresh consideration. Bangladesh approved Bt brinjal for cultivation in 2013, illustrating divergent regional outcomes for the same crop.

GMO must be distinguished from adjacent concepts. It is broader than the gene-edited organism, which under emerging Indian regulation may escape full biosafety review if no transgene persists; the legal question turns on whether foreign genetic material is present. GMO is also distinct from biofortification, which can be achieved through conventional breeding without recombinant techniques, as in the case of some high-zinc wheat varieties. It differs from "hybrid" seeds, which result from controlled cross-pollination within compatible species and involve no laboratory gene transfer. The Cartagena Protocol's LMO terminology specifically denotes a living, replicable organism, excluding processed derivatives such as refined GM soybean oil that contain no viable genetic material.

Controversy surrounds GMOs on grounds of biosafety, seed sovereignty, and agrarian economics. Critics cite gene flow to wild relatives, herbicide-tolerance traits that may entrench chemical dependency, and the concentration of seed patents among multinational firms. The Bt brinjal moratorium and the GM mustard litigation reflect the unresolved tension between the precautionary principle and the promise of yield and import-substitution gains, particularly for edible oils where India relies heavily on imports. The Technical Expert Committee appointed by the Supreme Court in the 2012 Aruna Rodrigues public interest litigation recommended caution on open-field trials, while subsequent expert opinion has favoured case-by-case scientific assessment. The 2022 gene-editing exemption itself drew objections that it bypassed adequate environmental scrutiny.

For the working practitioner—whether a UPSC aspirant addressing GS Paper III, a desk officer, or a policy analyst—the GMO file sits at the intersection of biotechnology, food security, trade, and constitutional environmental jurisprudence. Mastery requires fluency in the 1989 Rules and the GEAC-RCGM-IBSC hierarchy, the distinction between transgenic and gene-edited categories, the single approved Bt cotton precedent against the stalled Bt brinjal and contested GM mustard cases, and India's obligations under the Cartagena Protocol. The subject recurs in examination and policy debate because it forces a reasoned position on the precautionary principle versus innovation-led agricultural transformation, and because the regulatory map is actively shifting as genome editing outpaces the statutory framework drafted for an earlier technological era.